![]() |
Volumn 36, Issue 9 I, 2007, Pages 1207-1208
|
Paclitaxel-induced lupus;Lupus induit par le paclitaxel
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINUCLEAR ANTIBODY;
CARBOPLATIN;
DEXTROPROPOXYPHENE PLUS PARACETAMOL;
DI ANTALVIC;
FLUINDIONE;
FOSINOPRIL;
FOZIRETIC;
HYDROCHLOROTHIAZIDE;
IMMUNOGLOBULIN M;
PACLITAXEL;
PROCYANIDOL OLIGOMER;
RECOMBINANT ERYTHROPOIETIN;
UNCLASSIFIED DRUG;
ANTIINFLAMMATORY AGENT;
ANTINEOPLASTIC AGENT;
BETAMETHASONE;
BETAMETHASONE DIPROPIONATE;
BETAMETHASONE-17,21-DIPROPIONATE;
DRUG DERIVATIVE;
AGED;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER STAGING;
CASE REPORT;
CLINICAL FEATURE;
DISEASE COURSE;
DRUG INDUCED DISEASE;
FEMALE;
HUMAN;
HUMAN TISSUE;
LUPUS VULGARIS;
OVARY CARCINOMA;
RADIODENSITOMETRY;
RECURRENT DISEASE;
SKIN BIOPSY;
TREATMENT OUTCOME;
BIOPSY;
CHEMICALLY INDUCED DISORDER;
DRUG COMBINATION;
IMMUNOLOGY;
OVARY TUMOR;
PATHOLOGY;
SKIN;
SKIN LUPUS ERYTHEMATOSUS;
AGED;
ANTI-INFLAMMATORY AGENTS;
ANTIBODIES, ANTINUCLEAR;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
BETAMETHASONE;
BIOPSY;
DRUG THERAPY, COMBINATION;
ERYTHROPOIETIN, RECOMBINANT;
FEMALE;
HUMANS;
LUPUS ERYTHEMATOSUS, CUTANEOUS;
OVARIAN NEOPLASMS;
PACLITAXEL;
RECURRENCE;
SKIN;
TREATMENT OUTCOME;
|
EID: 34548169275
PISSN: 07554982
EISSN: None
Source Type: Journal
DOI: 10.1016/j.lpm.2007.02.032 Document Type: Article |
Times cited : (11)
|
References (3)
|